um-ids/dailymed-annotations huggingface dataset:
INDICATIONS AND USAGE
The use of metoclopramide tablets is recommended for adults only. Therapy should not exceed 12 weeks in duration.
Symptomatic Gastroesophageal Reflux
Metoclopramide tablets are indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy.
The principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms. If symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather than using the drug throughout the day. Healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12-week trial using doses of 15 mg q.i.d.
As there is no documented correlation between symptoms and healing of esophageal lesions, patients with documented lesions should be monitored endoscopically.
Diabetic Gastroparesis (Diabetic Gastric Stasis)
Metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. The usual manifestations of delayed gastric emptying (e.g., nausea, vomiting, heartburn, persistent fullness after meals, and anorexia) appear to respond to metoclopramide within different time intervals. Significant relief of nausea occurs early and continues to improve over a three-week period. Relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more.
1 INDICATIONS AND USAGE
FIRMAGON is indicated for treatment of patients with advanced prostate cancer.
FIRMAGON is a GnRH receptor antagonist indicated for treatment of patients with advanced prostate cancer. (1)
1.
INDICATIONS AND USAGE
VRAYLAR is indicated for the:
Treatment of schizophrenia in adults
[see Clinical Studies (
14.1
)]
Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults
[see Clinical Studies (
14.2
)]
Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults
[see Clinical Studies (
14.3
)]
VRAYLARis anatypical antipsychoticindicated for the:
Treatment of schizophrenia in adults (
1)
Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults (
1)
Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults (
1)
1 INDICATIONS AND USAGE
Fluoxetine is indicated for the treatment of:
Acute and maintenance treatment of Major Depressive Disorder [see Clinical Studies (14.1)].
Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD) [see Clinical Studies (14.2)].
Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa [see Clinical Studies (14.3)].
Acute treatment of Panic Disorder, with or without agoraphobia [see Clinical Studies (14.4)].
Fluoxetine
and Olanzapine in Combination is indicated for the treatment of:
Acute treatment of depressive episodes associated with Bipolar I Disorder.
Treatment resistant depression (Major Depressive Disorder in patients, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
Fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression.
When using fluoxetine and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax .
Fluoxetine capsules are a selective serotonin reuptake inhibitor indicated for:
Acute and maintenance treatment of Major Depressive Disorder (MDD) (1)
Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) (1)
Acute and maintenance treatment of Bulimia Nervosa (1)
Acute treatment of Panic Disorder, with or without agoraphobia (1)
Fluoxetine capsules and olanzapine in combination for treatment of:
Acute Depressive Episodes Associated with Bipolar I Disorder (1)
Treatment Resistant Depression (1)
INDICATIONS AND USAGE:
Naropin is indicated for the production of local or regional anesthesia for surgery and for acute pain management.
Image3.jpg
INDICATIONS AND USAGE
Nateglinide Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
INDICATIONS AND USAGE
THIS IS NOT AN INNOCUOUS DRUG. IT IS NOT RECOMMENDED FOR THE
TREATMENT OF ASYMPTOMATIC HYPERURICEMIA. Allopurinol reduces serum and
urinary uric acid concentrations. Its use should be individualized for each
patient and requires an understanding of its mode of action and
pharmacokinetics (see
CLINICAL PHARMACOLOGY
,
CONTRAINDICATIONS
,
WARNINGS
and
PRECAUTIONS
).
Allopurinol is indicated in:
the management of patients with signs and symptoms of primary
or secondary gout (acute attacks, tophi, joint destruction, uric acid
lithiasis and/or nephropathy).
the management of patients with leukemia, lymphoma and
malignancies who are receiving cancer therapy which causes elevations of
serum and urinary uric acid levels. Allopurinol treatment should be
discontinued when the potential for overproduction of uric acid is no
longer present.
the management of patients with recurrent calcium oxalate
calculi whose daily uric acid excretion exceeds 800mg/day in male
patients and 750 mg/day in female patients. Therapy in such patients
should be carefully assessed initially and reassessed periodically to
determine in each case that treatment is beneficial and that the benefits
outweigh the risks.